testosterone undecanoate has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doros, G; Haider, A; Hammerer, P; Isbarn, H; Yassin, A; Zitzmann, M | 1 |
| Balbontin, FG; Bley, E; Chacon, R; Moreno, SA; Morgentaler, A; Silva, A | 1 |
| Khupulsup, K; Leelaphiwat, S; Pavavattananusorn, S; Permpongkosol, S; Petchthong, T; Thongpradit, S | 1 |
3 other study(ies) available for testosterone undecanoate and Prostatic Neoplasms
| Article | Year |
|---|---|
Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Follow-Up Studies; Humans; Hypogonadism; Incidence; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Registries; Testosterone; Time Factors | 2015 |
Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.
Topics: Aged; Androgens; Brachytherapy; Humans; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Surveys and Questionnaires; Testosterone; Treatment Outcome | 2014 |
Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Topics: Aged; Androgens; Bone Density; Drug Administration Schedule; Follow-Up Studies; Humans; Hypogonadism; Libido; Lipoproteins, HDL; Male; Middle Aged; Obesity; Orgasm; Patient Satisfaction; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Testosterone; Triglycerides; Waist Circumference | 2016 |